Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
IPDN Professional shares sink 946 after posting negative Q2 2023 EPS with no analyst consensus estimates CYN Cyngn falls 457 after Q3 2025 EPS misses analyst estimates by 188 percent iShares Russell 2000 ETF IWM Geopolitical and Energy Risk Disconnect Amid Strong SmallCap Rally NVT nVent delivers narrow Q4 2025 EPS miss sending share price down 067 percent in todays trading Renewed RussiaUkraine Conflict Escalation Raises Market Uncertainty NVIDIAs Market Cap Surpasses Germanys GDP as Big Tech Dominance Grows Googles AI Chip Expansion May Pressure Nvidia and Cloud Rivals CoreWeave and Nebius ICRA Flags Sharp Decline in IBC Recovery Rates to 22 in H2 FY26 Mortgage Rates Edge Up to 653 Adding Pressure on Spring Homebuyer Demand Stellantis Turnaround Strategy Prediction Market Crackdown and Oura IPO Lead Morning Market News NCS Multistage Holdings Inc NCSM Q1 2026 Earnings EPS Misses Estimates Significantly Revenue Data Unavailable ALZN Q1 2026 Earnings Narrowing Losses Beat Estimates by 70 ITT Inc Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response IIIN Q1 2026 Earnings EPS Misses Estimates as Steel Wire Demand Softens Stock Gains Despite Shortfall SEDG Q1 2026 Earnings EPS Miss by 50 Solar Market Headwinds Persist MBC Q1 2026 Earnings EPS Surges 69 Above Estimates Shares Jump 127 LifeMD LFMD Slips 066 as Stock Hovers Near Established Support Level John Hancock Preferred Income Fund III HPS Edges Higher Amid Modest Trading Activity MITN Slips 05 Amid FixedIncome Volatility Technical Levels Hold Xsolla SPAC 1 Units XSLLU Holds Steady at 998 Neutral Stance Ahead of Catalysts JELDWEN Holding Inc JELD Stages a Modest Recovery Navigating Support and Resistance Levels JNJ Q1 2026 Earnings Slight EPS Beat Amidst Operational Strength NTRB Q1 2026 Earnings Massive EPS Beat Highlights Cost Control Amid PreRevenue Stage RWAYI Q1 2026 Earnings EPS Miss Amidst Narrowed Lending Margins BHFAM Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions Verrica Pharmaceuticals VRCA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Sees Modest Stock Gain